Advertisement

Topics

ACTS selects two drugs for Alzheimer’s for clinical trials

12:44 EDT 14 May 2019 | Outsourcing-Pharma

Japanese pharmaceutical company Eisai sends two new Alzheimerâs prevention drugs into the clinic after ACTC selection.

Original Article: ACTS selects two drugs for Alzheimer’s for clinical trials

NEXT ARTICLE

More From BioPortfolio on "ACTS selects two drugs for Alzheimer’s for clinical trials"

Advertisement
Quick Search
Advertisement
Advertisement